tumor, Cancer
TUMOR, CANCER
The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 items (QLQ‐C30),The key clinical cycles were week 12 (cycle 4) and week 18 (cycle 6) and were selected to measure change in PRO endpoints at the end of chemotherapy (week 12) and after chemotherapy treatment (week 18) close to the clinical scheduled visit for tumor assessment. At the start of each visit, patients were requested to answer the questionnaires before clinical assessments or intervention.